The Jan. 1 drug pricing changes are a cash flow problem, not a margin problem
It’s the end of the world as we know it; panic and mass hysteria. That is roughly the tone of recent coverage of the pharmacy changes arriving in 2027, and it is worth turning the volume down, because the truth is more complicated and considerably more useful. Three federal changes land on the same prescription […] The post The Jan. 1 drug pricing changes are a cash flow problem, not a margin problem appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.